COVID-19 Infection clinical trials
106 active trials name this condition. Describe your situation to see which ones you may be eligible for.
Refine by biomarker
By location
- A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- Phase 2 Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory Failure
- A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
- Defibrotide for the Treatment of Severe COVID-19
- Careful Ventilation in Acute Respiratory Distress Syndrome (COVID-19 and Non-COVID-19)
- EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease
- REmotely Monitored, Mobile Health Supported Multidomain Rehabilitation Program With High Intensity Interval Training for COVID-19
- Mitoquinone/Mitoquinol Mesylate as Oral and Safe Postexposure Prophylaxis for Covid-19
- Home-Based Exercise Tele-Rehabilitation After COVID-19
- SARS-CoV-2 CTLS for Mild to Moderate COVID-19 Disease
- Convalescent Plasma as a Possible Treatment for COVID-19
- Low Dose Whole Lung Radiation Therapy for Patients With COVID-19 and Respiratory Compromise
- Medical Herbs Inhibit Inflammation Directing T Cells to Kill the COVID-19 Virus (COVID)
- Arginine Replacement Therapy in COVID-19
- Percutaneous Electrical Nerve Field Stimulation (PENFS) in Patients With Post Concussion Syndrome (PCS)
- A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
- Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
- Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
- Phase 2a Multiple Ascending Dose Study in Hospitalized Patients With Pneumonia.
- Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients
- Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions
- A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalational Routes in Previously Vaccinated Adults
- Vale+Tú Salud: Corner-Based Trial to Test a Latino Day Laborer Program Adapted to Prevent COVID-19
- A Phase 1/2A, Randomized Study of a T Follicular Helper (TFH)-Targeting Genetic Vaccine Strategy Designed to Induce Broad, Durable Immune Responses
- Connecting Friends and Health Workers to Boost COVID-19 Vaccination in Latino Communities
- A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations
- A Study Evaluating MDX2301 in Healthy Adults and Adults at Higher Risk for Severe COVID-19.
- T Cell Therapy Opposing Novel COVID-19 Infection in Immunocompromised Patients
- A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults
- Dime La VerDAD: Verify, Debunk, and Disseminate
- Clinical Validation of the Aptitude Medical Systems Metrix COVID-19 Test
- Positron Emission Tomography (PET) Imaging of Thrombosis
- A Multi-Site Clinical Evaluation of the LIAISON NES FLU A/B, RSV & COVID-19 Assay in Symptomatic Patients
- A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age
- Clazakizumab vs. Placebo - COVID-19 Infection
- Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
- Dissecting Human Immune Responses to Infection With Influenza or SARS-CoV-2
- Dysbiosis & Long COVID
- Cross-Sectional Evaluation of Persistence of SARS-CoV-2 Remnants After Recovery From Acute Infection
- The Measurement of Chemicals in Exhaled Breath Can Identify If a Person is Infected with COVID-19
- Passive Detection- SARS-CoV-2 (COVID-19) A&M Breathalyzer (PROTECT Kiosk) for Operational Medicine
- A Study of Post COVID-19 Mechanisms for Chronic Lung Sequelae
- COVID-19 Transmission and Morbidity in Malawi
- Researchers At UC San Diego Are Learning About the Benefits of Human Milk and How It Influences Infant and Child Health
- COVID-19 Coagulopathy Extension Study
- Respiratory Virus Sampling and Repository
- The Impact of COVID-19 on Maternal and Neonatal Outcomes
- COVID-19 International Drug Pregnancy Registry
- Women s Health Awareness Community Resiliency, Environmental Action and Collaborations for Health (REACH) Equity
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “COVID-19 Infection” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.